Drug factory · FDA FEI 3003671557

G Production Inc

19400 RTE Transcanadienne, Baie D'Urfe, Canada

Canada: 1

No problems found at FDA's last inspection, Feb 17, 2023.

No Action Indicated: inspectors found no objectionable conditions.

6 drug inspections on record since 2009: 5 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AdapaleneMakes it Galderma Laboratories, L.P., Mayne Pharma Inc., Padagis Israel Pharmaceuticals Ltd 0299-5918, 68308-666, 45802-453
Adapalene and Benzoyl PeroxideMakes it Mayne Pharma Inc. 68308-662
BrimonidineMakes it Galderma Laboratories, L.P. 0299-5980
CalcitriolMakes it Galderma Laboratories, L.P., Padagis Israel Pharmaceuticals Ltd 0299-2012, 45802-608
ClobetasolMakes it Mayne Pharma Inc. 68308-664
DesonideMakes it Actavis Pharma, Inc. 0472-0803, 0472-0804
Fluocinolone Acetonide and Hydroquinone and TretinoinMakes it Galderma Laboratories, L.P. 0299-5950
IvermectinMakes it Galderma Laboratories, L.P., Mayne Pharma Inc. 0299-3823, 68308-701
MetronidazoleMakes it Mayne Pharma Inc., Prasco Laboratories 68308-663, 68308-711, 68308-712 +1
TrifaroteneMakes it Galderma Laboratories, L.P. 0299-5935

FDA inspection history

EndedResultProgramProblems noted
Feb 17, 2023No problems foundDrug Quality Assurance—
Dec 8, 2017Problems found, fixed voluntarilyDrug Quality Assurance1
Feb 13, 2015No problems foundDrug Quality Assurance—
May 17, 2013No problems foundDrug Quality Assurance—
Sep 29, 2011No problems foundDrug Quality Assurance—
Sep 4, 2009No problems foundDrug Quality Assurance—

What inspectors wrote down

From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.

Dec 8, 2017 inspection

Registered with FDA for: analysis; label; manufacture; pack.